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Background: Acute surgery in the management of malignant colonic obstruction is associated with high
morbidity and mortality. The use of self-expanding metal stents (SEMS) is an alternative method of decompressing
colonic obstruction. SEMS may allow time to optimize the patient and to perform preoperative staging, converting
acute surgery into elective. SEMS is also proposed as palliative treatment in patients with contraindications to open
surgery. Aim: To review our experience of SEMS focusing on clinical outcome and complications. The method used
was a review of 75 consecutive trials at SEMS on 71 patients based on stent-protocols and patient charts.
Findings: SEMS was used for palliation in 64 (85%) cases and as a bridge to surgery in 11 (15%) cases. The majority of
obstructions, 53 (71%) cases, were located in the recto-sigmoid. Technical success was achieved in 65 (87%) cases and
clinical decompression was achieved in 60 (80%) cases. Reasons for technical failure were inability to cannulate the
stricture in 5 (7%) cases and suboptimal SEMS placement in 3 (4%) cases. Complications included 4 (5%) procedure-
related bowel perforations of which 2 (3%) patients died in junction to post operative complications. Three cases of
bleeding after SEMS occurred, none of which needed invasive treatment. Five of the SEMS occluded. Two cases of stent
erosion were diagnosed at the time of surgery. Average survival after palliative SEMS treatment was 6 months.
Conclusion: Our results correspond well to previously published data and we conclude that SEMS is a relatively
safe and effective method of treating malignant colonic obstruction although the risk of SEMS-related perforations
has to be taken into account.
Background
Acute or pending colonic obstruction, on the basis of
colorectal malignancy, is a condition traditionally treated
with surgery with a single or a multi-stage operative
procedure. Acute surgery with colonic resection and pri-
mary anastomosis with or without a diverting stoma is
the most common surgical approach in relatively healthy
patients. The multi-stage approach includes initial
decompression of the obstruction with a temporary
colostomy and a later colonic resection with reversal of
the stoma if possible. This method is mainly considered
in patients with deteriorated general condition, serious
co-morbidity or in cases with advanced tumors. Regard-
less of the technique used, surgical procedures are asso-
ciated with a high morbidity and mortality rate [1]. The
use of self-expanding metal stents (SEMS) for
decompression of colonic obstructions was first
described by Spinelli et al [2] in 1992 as a palliative
treatment. In 1994, Tejero et al [3] published a preli-
minary report on the use of SEMS as a temporary treat-
ment as a bridge to surgery, relieving the patient of the
obstruction without the need for emergency bowel sur-
gery. This allows time for optimization of the patient’s
physiological parameters, completion of preoperative
staging and conversion of an acute surgical intervention
into an elective procedure. The method has since then
been taken into clinical practice internationally and in
Sweden, both for palliative treatment and as a bridge to
surgery [4-18].
The aim of this study was to review our series of cases
with regards to technical and clinical outcome and
complications.
Methods
Patient documentation was reviewed retrospectively in
75 consecutive attempts at placing SEMS on 71 patients
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any medium, provided the original work is properly cited.(47 men, 24 women). The procedures were performed
during a six-year period. The mean age of the patients
was 74 years. In 64 (85%) cases, the indication was pal-
liative treatment. In 11 (15%) cases, the intention was
bridge to surgery, with the intention to perform elective
surgery after patient optimization and possibly further
diagnostic procedures.
The diagnosis of colonic obstruction was based on
clinical signs, such as abdominal distension, constipation
and supportive radiological work-up. Computed tomo-
graphy (CT) was performed in 64 (90%) patients, colo-
noscopy in 32 (45%), water soluble contrast enema (CE)
in 25 (35%), plain abdominal x-ray in 23 (32%) and rec-
toscopy in nine (13%) patients.
All patients were conscious during SEMS deployment
and had the opportunity to receive conscious sedation
in the form of midazolam hydrochloride (F. Hoffmann-
La Roche Ltd. Basel, Switzerland) and analgesia with
ketobemidon chloride (Pfizer Inc. New York, USA)
intravenously. Combined endoscopic and radiological
techniques were used, where the distal end of the
obstruction was located endoscopically. After placing a
guide-wire through the obstruction, an endoscopic fill-
ing catheter was inserted over the guide-wire. Water-
soluble contrast medium was injected to visualize the
proximal end of the tumor. After reinserting the guide-
wire, the catheter was removed and the stent was
inserted and deployed. Stent expansion was confirmed
with a radiological control image immediately after
deployment. In three (4%) cases, there was a need to
place a second stent coaxially in the first one to get an
adequate coverage of the obstruction. Boston Scientific
Wall-stent and Wall-Flex stents (Boston Scientific/
Microvasive, Natick, MA, USA) were used; 22 nine-cm
Wall-Flex, 28 12-cm Wall-Flex, two six-cm Wall-Stents,
15 nine-cm Wall-Stents and one 12-cm Wall-Stent.
This research is in compliance with the Helsinki
declaration and has been approved by the regional
research ethics board at Lund University, Sweden.
Findings
The sigmoid and recto-sigmoid junctions were the most
common locations of the obstruction, representing 31
(44%) and 15 (21%) cases respectively. Five (7%) lesions
were found in the rectum, nine (13%) obstructions were
located at the splenic flexure and eleven (15%) obstruc-
tions were located proximal to this. The median stric-
ture length was four cm (range 2-10 cm). Technical
success was visually defined as adequate stent placement
overlapping the proximal and distal end of the stricture
by two cm with a clear-cut waist line of the stent on a
plain radiograph. This was achieved in 65 (87%)
attempts. Notably, faecal flow through the stent was
registered in 30 (46%) cases at the end of a technically
successful procedure, indicating immediate functional
decompression. Clinical decompression was defined as
stool and gas passage within 48 hours after stent deploy-
ment, which was achieved in 60 of 75 cases, resulting in
a clinical success rate of 80% success rate of all attempts
made or 92% of the technically successful cases. In two
additional cases, clinical decompression was achieved
within one week after prolonged intestinal paralysis.
Reasons for technical failure were failure to cannulise
the stricture with the guide-wire, which made stenting
impossible in six (8%) cases and incorrect stent place-
ment in three (4%) cases. In one case, the tumor was
not sufficiently stenotic and the SEMS migrated distally
immediately after placement. It was removed during the
same procedure. The average time for the entire proce-
dure was 68 min (range 13-171 min).
In the eleven patients stented as bridge to surgery,
operations were all open laparotomies performed one to
31 days after stent placement with one outlier at 90
days post-SEMS treatment due to administration of
neoadjuvant chemotherapy. In eight patients, a one
stage curative operation with primary anastomosis was
performed. Two patients underwent a Hartmann’sp r o -
cedure with a left colon end stoma and one patient with
advanced malignancy had a diverting stoma as the only
treatment.
In terms of clinical complications, we observed four
cases (5%) of supposed stent procedure-related bowel
perforation. In two cases, perforation of the caecum was
detected shortly after stent placement in colon. These
patients underwent acute open surgery but both died of
complications one and 16 days postoperatively. In the
third case, CT shortly after the procedure showed a cov-
ered perforation in the mesentery adjacent to the stent.
This patient did not develop peritonitis and was treated
conservatively with successful outcome. A forth case of
perforation occurred, in which the catheter and guide-
wire perforated the bowel wall in a necrotic tumor area
and contrast fluid was detected in the abdominal cavity
upon injection. This patient was not stented and under-
went emergency surgery and tumor resection without
further complications. Stent erosion through the bowel
wall, presumably due to mechanical forces, was detected
in two patients; one in junction to surgery and one
described by the pathologist. These two patients were
operated on eight and 23 days after stent placement.
Both patients had a Wall-Flex 12 cm stent. None of
them had any visible leakage of bowel content but
merely a localized inflammatory reaction with the
mesentery covering the site of erosion. Stent occlusion
occurred in five cases (7%) after 75, 79, 95, 130 and 195
days. One case was decompressed by restenting and one
by flushing the occlusion via colonoscopy. One under-
went re-stenting but never decompressed clinically.
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stent occlusions, a Wall-Flex 12 cm stent was used. In
three cases (4%), a macroscopic bleeding was observed
after the procedure, presumably induced by the stent
deployment. All cases of SEMS-related bleeding seized
spontaneously. One case of stent migration occurred in
a patient who had chemotherapy after SEMS treatment.
In this case, the stent was washed out with the stool
after nearly three months and just prior to planned
surgery.
The average survival time after palliative stenting was
six months with an average follow-up time of 18
months. Of the 11 patients undergoing stenting as a
bridge to surgery, two patients with serious co-morbidity
died shortly after surgery. One went abroad without any
possibility to follow up. The other eight cases success-
fully underwent elective surgery without complications
and were all still alive at the time of data collection.
Discussion
Primary colorectal carcinoma is one of the most com-
mon causes of colonic obstruction. Acute obstructive
symptoms are the first presentation of illness in seven
to 30% of the patients [19-21]. An acute surgical proce-
dure has traditionally been used to ameliorate the
obstruction. In general, a two or three stage operative
strategy has been used where decompression are
achieved by colostomy combined with tumor resection
primarily or as a second procedure and stoma reversal
in a second or third operation [22]. Stoma reversal is
often abandoned in cases of advanced malignancy or
serious co-morbidity [21,23]. Due to high morbidity and
mortality rates [20], a strategy based on primary resec-
tion and anastomosis has been advocated. This strategy
is now accepted as the standard surgical treatment in
most cases [24-26] although there is no evidence that
one therapeutic approach is superior to the other [1]. In
cases with advanced cancer, a palliative and permanent
end colostomy for bowel decompression has been the
treatment of choice. However, this procedure is also
associated with high morbidity and mortality rates. Con-
sidering the high risks involved in emergency surgery, a
less traumatic way of decompressing the obstruction is
of great interest.
During the last 15 to 20 years, SEMS have become the
major endoscopic method to relieve malignant colonic
obstruction, both as a palliative measure and as a tem-
porary treatment before elective surgery [4-18]. SEMS as
a bridge to surgery has also been compared to acute
operation with favorable clinical outcome
[10,14-18,27,28]. Complication rates after SEMS com-
pared to surgical intervention are generally lower and of
a less serious nature in most studies. An exception is
the Dutch multicenter study, in which an unexpected
high rate of perforations led to early closure [29]. SEMS
as bridge to surgery allows a higher frequency of pri-
mary anastomosis when compared to emergency surgery
and there are no significant differences in survival
between the groups [30]. SEMS used as a palliative
treatment are generally patent until the death of patients
due to underlying malignancy. Notably, there is a very
low rate of mortality related to SEMS complications in
most studies [17]. Quality of life is also maintained at
an acceptable level in patients treated with palliative
SEMS [31]. Another advantage of palliative SEMS is that
chemotherapy treatment can be administered earlier
than after major surgery and in some cases allowing
downgrading of the tumor for later liver surgery of
metastasis [15]. As a conclusion, previous studies have
shown that SEMS have the potential of reducing mor-
bidity and mortality related to the management of acute
malignant colonic obstruction if performed in a safe and
effective way.
The present study focuses on procedural and clinical
results, of SEMS treatment in our hands. Our technical
success rate of 87% correlates well with previous find-
ings, which frequently range between 66-100% in the lit-
erature. Considering that this study comprises all
colonic SEMS undertaken in our centre and therefore
may include a learning curve component for the endos-
copists, the results are acceptable. A clinical success rate
of 80% is also in accordance with other studies with a
clinical success rate ranging between 46-100% [32]. The
majority of obstructions were located in the recto-sig-
moid area representing 71% of the cases. This is also in
line with previous studies showing a predominance of
left side colonic lesions around 70% [33]. In general,
complications after SEMS arer e p o r t e dt ob er e l a t i v e l y
few. In our study, the most serious complication was
bowel perforation, which occurred in four (6%) SEMS
cases. Two of these patients died due to complications
of the subsequent emergency surgery. It is interesting to
note that the level of serious morbidity has been
reported to be around 4-5% of the cases according to a
review by Watt et al [32]. In two other cases, stent ero-
sion through the bowel wall was detected at the time of
surgery. In neither case did the erosion lead to any sig-
nificant leakage or peritonitis. Other less serious compli-
cations included minor bleeding, presumably from the
SEMS site in three (4%) cases and stent occlusion,
which occurred in five (7%) cases.
Conclusion
T h i ss t u d ys h o w st h a tS E M Si sar e a s o n a b l ys a f ea n d
effective procedure for treating obstructing colorectal
carcinoma. The method has relatively few serious com-
plications, although two perforations with lethal conse-
quence are significant. A limitation of this study is its
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Further prospective randomized studies comparing
SEMS with emergency surgery would be of great benefit.
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